Cargando…
Chinese Vaccine Providers’ Perspectives on the HPV Vaccine
China approved a human papillomavirus (HPV) vaccine in 2018. Recommendations from health care providers can positively impact vaccine receipt. This study characterized vaccine providers’ attitudes toward the HPV vaccine and contrasted attitudes by the providers’ demographic characteristics. In total...
Autores principales: | Ji, Mengdi, Huang, Zhuoying, Ren, Jia, Sun, Xiaodong, Wagner, Abram L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597565/ https://www.ncbi.nlm.nih.gov/pubmed/33195744 http://dx.doi.org/10.1177/2333794X20967592 |
Ejemplares similares
-
Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China
por: Ji, Mengdi, et al.
Publicado: (2022) -
Stronger responders—uptake and decline of HPV-vaccination in Denmark
por: Lübker, Charlotte Lynderup, et al.
Publicado: (2019) -
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
por: Mesher, David, et al.
Publicado: (2016) -
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022) -
The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers
por: MacDougall, D M, et al.
Publicado: (2015)